Natural history of compensated cirrhosis in the Child-Pugh class a compared between 490 patients with hepatitis C and 167 with B virus infections
- 15 February 2006
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 78 (4) , 459-465
Abstract
Natural histories of compensated cirrhosis in the Child‐Pugh class A were compared between the 490 patients infected with hepatitis C virus (HCV) and 167 patients with hepatitis B virus (HBV) who were followed for more than 1 year up to 20 years without antiviral treatment. Patients with HCV were older (median age: 59 vs. 45 years), less predominantly male (59.0% vs. 76.0%), transfused more frequently (49.2% vs. 9.0%), and had higher aminotransferase as well as lower albumin levels and fewer platelets (P < 0.001 for all). Death was commoner (55.1% vs. 35.9%, P < 0.001) and hepatocellular carcinoma developed more often (53.9% vs. 28.7%, P < 0.001) in patients with HCV than HBV. In multivariate analysis, low albumin levels (hazard ratio: 1.65), α‐fetoprotein (1.55), alcohol consumption (1.49), age >55 years (1.47), and retention of indocyanine green (1.39) were independent risk factors for the survival in patients with HCV, while male gender (4.43), age >45 years (2.24), retention of indocyanine green (2.14), hepatitis B e antigen (2.11), and low platelet counts (1.91) were in those with HBV. Chances for survival was significantly different (P < 0.001) among patients with HCV having low (number of factors: 0–1), medium (2–3), and high risks (4–5), as well as in those with HBV having low (0–1), medium (2–4), and high risks (5–6). In conclusion, survival and development of hepatocellular carcinoma, and factors for survival, are considerably different between patients with compensated cirrhosis infected with HCV and HBV, which would need to be taken into consideration in their management and planning treatment strategies. J. Med. Virol. 78:459–465, 2006.Keywords
This publication has 34 references indexed in Scilit:
- Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complicationsGut, 2004
- Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patientsAmerican Journal of Gastroenterology, 2002
- Hepatitis B viral genotypes: Clinical relevance and molecular characteristicsJournal of Gastroenterology and Hepatology, 2002
- The Scientific Challenge of Hepatitis CScience, 1999
- Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosisCancer, 1999
- The Long–Term Outcomes of Patients With Compensated Hepatitis C Virus-Related Cirrhosis and History of Parenteral Exposure in the United StatesHepatology, 1999
- Retrospective analysis of the effect of interferon therapy on the clinical outcome of patients with viral cirrhosisCancer, 1998
- Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis CHepatology, 1998
- Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patientsGastroenterology, 1997
- Genotypic subtyping of hepatitis C virusJournal of Gastroenterology and Hepatology, 1993